1. Home
  2. MGYR vs RANI Comparison

MGYR vs RANI Comparison

Compare MGYR & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$16.10

Market Cap

115.2M

Sector

Finance

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.14

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
RANI
Founded
1922
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
126.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MGYR
RANI
Price
$16.10
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
8.5K
871.5K
Earning Date
04-29-2026
03-26-2026
Dividend Yield
2.33%
N/A
EPS Growth
26.83
21.05
EPS
0.50
N/A
Revenue
N/A
$1,028,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
$34.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.52
$0.39
52 Week High
$20.00
$3.87

Technical Indicators

Market Signals
Indicator
MGYR
RANI
Relative Strength Index (RSI) 41.80 31.11
Support Level $16.81 $1.07
Resistance Level $17.21 $1.54
Average True Range (ATR) 0.35 0.08
MACD -0.04 -0.02
Stochastic Oscillator 18.95 1.61

Price Performance

Historical Comparison
MGYR
RANI

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: